RCKT STOCK ANALYSIS

Rocket Pharmaceuticals Inc — price, returns and risk statistics

RCKTRocket Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel

Price summary

Last Close

3.84 $

Jul 2, 26

Market Cap

430.6 M $

Q1 2026 (TTM)

52-Week Range

2.60 $5.30 $

Return and risk cards

Total Return

%+33.3

Trailing 1-year performance

Volatility

%78.7

Price fluctuation measure

Sharpe Ratio

0.24

Risk/Return ratio

Sortino Ratio

0.29

Downside risk/return

Distance to Peak

%-27.5

Difference from 52-week peak

Maximum Drawdown

-%50.9

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+32.9%

3M

+8.2%

6M

+9.4%

YTD

+9.4%

1Y

+33.3%

3Y

-80.8%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
RCKT+9.4%Gold-3.2%Silver-10.4%S&P 500+9.3%

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Rocket Pharmaceuticals Inc (RCKT) stock price?

RCKT last closed at 3.84 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the market capitalization of Rocket Pharmaceuticals Inc?

Rocket Pharmaceuticals Inc (RCKT) has a market capitalization of approximately 430.6 M $ as of the latest reported period.

Who are the main competitors of RCKT?

Key peers of Rocket Pharmaceuticals Inc include Mesoblast Ltd, TELIX Pharmaceuticals Ltd, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.. A detailed metric comparison is available on the Peers tab.

Go deeper on RCKT

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.